Concurrence between Guillain-Barré syndrome and immune thrombocytopenic purpura possibly induced by long COVID-19.
Rafael Pichardo-RodríguezJuan-Jesús Bracamonte-HernándezDiana-Cristina Ramírez-MeyhuayIngrid-Roxani Arquinigo-LavadoWilly Peña-OscuvilcaMarcos Saavedra-VelascoOscar Ruiz-FrancoPublished in: Revista peruana de medicina experimental y salud publica (2022)
During acute SARS-CoV-2 infection, there is persistent deregulation of the immune system that can last up to 8 months after the acute condition is controlled. This, added to other factors, is possibly associated with an increased risk of the appearance and concurrence of autoimmune diseases. The simultaneous occurrence of GBS and ITP has been rarely reported in the literature, and GBS is rarely associated with another autoimmune disease. We present the case of a man who, one month after his recovery from acute moderate COVID-19, presented concurrent GBS and ITP with an adequate response to treatment.
Keyphrases
- liver failure
- coronavirus disease
- respiratory failure
- drug induced
- sars cov
- aortic dissection
- systematic review
- respiratory syndrome coronavirus
- hepatitis b virus
- multiple sclerosis
- squamous cell carcinoma
- radiation therapy
- intensive care unit
- locally advanced
- acute respiratory distress syndrome
- replacement therapy